CRISPR Therapeutics AG
CRSP
29 insider filings · Latest: Jun 5, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Dec 22, 2025 | Dec 22 9:20 PM | RAJU PRASAD | Proposed Sale | 10,000 | $55.95 | $559.5K | — | View → |
| Feb 18, 2025 | Feb 18 10:35 PM | Samarth Kulkarni | Proposed Sale | 45,000 | $52.22 | $2.3M | — | View → |
| Nov 11, 2024 | Nov 12 1:07 PM | Dr. Samarth Kulkarni | Proposed Sale | 75,000 | $54.86 | $4.1M | — | View → |
← Previous
Page 2 of 2
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Mar 20, 2026 | Mar 24 9:36 PM | Naimish PatelChief Medical Officer | Grant/Award | 68,499 | $46.24 | 30,000(D) | View → |
| Mar 14, 2026 | Mar 17 9:37 PM | Naimish PatelChief Medical Officer | Option Exercise | 8,125 | — | 24,375(D) | View → |
| Mar 14, 2026 | Mar 17 9:37 PM | Raju PrasadChief Financial Officer | Option Exercise | 16,875 | — | 20,625(D) | View → |
| Mar 14, 2026 | Mar 17 9:35 PM | James R. KasingerGeneral Counsel and Secretary | Option Exercise | 6,875 | — | 20,625(D) | View → |
| Mar 14, 2026 | Mar 17 9:35 PM | Samarth KulkarniDirector, Chief Executive Officer | Option Exercise | 20,625 | — | 61,875(D) | View → |
| Mar 10, 2026 | Mar 12 9:35 PM | James R. KasingerGeneral Counsel and Secretary | Option Exercise | 5,500 | — | 5,500(D) | View → |
| Mar 10, 2026 | Mar 12 9:35 PM | Samarth KulkarniDirector, Chief Executive Officer | Option Exercise | 19,250 | — | 19,250(D) | View → |
| Feb 18, 2026 | Feb 20 10:36 PM | Samarth KulkarniDirector, Chief Executive Officer | Option Exercise | 13,250 | — | 0(D) | View → |
| Feb 18, 2026 | Feb 20 10:35 PM | James R. KasingerGeneral Counsel and Secretary | Option Exercise | 3,825 | — | 0(D) | View → |
| Jan 22, 2026 | Jan 26 10:35 PM | Raju PrasadChief Financial Officer | Option Exercise | 34,972 | $45.15 | 41,667(D) | View → |
← Previous
Page 2 of 2